This research program involves three interrelated and interacting projects that will use novel approaches to elucidate regulatory mechanisms in acute myocardial ischemia, injury, repair, and heart failure that have relevance to human cardiac disease. The overall proposal will make extensive use of transgenic and gene targeted deletion models in mice. Methods will include biochemical and molecular approaches in isolated submitochondrial particles and intact mitochondria; biochemical and molecular studies in cell culture; biophysical studies in isolated cells and myocardial strips; hemodynamic investigations in isolated hearts; and serial hemodynamic and echocardiographic studies in living animals. All of the required techniques are currently in use in the laboratories of the responsible investigators. Cellular and molecular processes not previously investigated in the heart will be targeted. The first overall goal is to learn about how the lysophospholipid mediators sphingosine I -phosphate and lysophosphatidic acid and the actin regulatory protein gelsolin regulate myocardial responses to acute oxidative stress, injury, and remodeling.
The second aim i s to study the molecular regulation of matrix metalloproteinase-2 (gelatinase A) in cardiac fibroblast proliferation, extracellular matrix formation, and cardiac remodeling.
The third aim i s to learn how calcium responsiveness is regulated in models of acute myocardial ischernia and reversible congestive heart failure. These projects will rely on three Core Units: a hemodynamics core, a cell culture core, and a transgenic mouse core. Each of the projects will have extensive interactions with the other projects and with the core units. This proposal brings together the skills of a diverse group of investigators united by an interest in understanding mechanisms underlying the heart's response to oxidative stress. The proposed studies are novel and feasible, and are designed to lead to new approaches for the prevention of myocardial damage during acute and chronic oxidative stress.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL068738-04
Application #
6929831
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Liang, Isabella Y
Project Start
2002-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$1,828,528
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
613338789
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Karliner, Joel S (2013) Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. Biochim Biophys Acta 1831:203-12
Kawabori, Masahito; Kacimi, Rachid; Karliner, Joel S et al. (2013) Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets. World J Cardiol 5:75-86
Lovett, David H; Mahimkar, Rajeev; Raffai, Robert L et al. (2013) N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS One 8:e68154
Lovett, David H; Mahimkar, Rajeev; Raffai, Robert L et al. (2012) A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS One 7:e34177
Dahi, Sia; Karliner, Joel S; Sarkar, Rajabrata et al. (2011) Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia. Int J Exp Pathol 92:50-6
Vessey, Donald A; Li, Luyi; Jin, Zhu-Qiu et al. (2011) A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longev 2011:961059
Kotlyar, Alexander B; Randazzo, Antonio; Honbo, Norman et al. (2010) Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase. FEBS Lett 584:159-65
Wang, Guan-Ying; Yeh, Che-Chung; Jensen, Brian C et al. (2010) Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive. Am J Physiol Heart Circ Physiol 298:H913-20
Chatterjee, Kanu; Zhang, Jianqing; Honbo, Norman et al. (2010) Doxorubicin cardiomyopathy. Cardiology 115:155-62
Tao, Rong; Hoover, Holly E; Honbo, Norman et al. (2010) High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 298:H1022-8

Showing the most recent 10 out of 56 publications